Rare diseases
Investigational molecules
Locations
Back to the Netherlands97 clinical trials in Alkmaar, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps
The NetherlandsStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
The NetherlandsStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
The NetherlandsStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
The NetherlandsStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
The NetherlandsStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
The NetherlandsStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
The NetherlandsLong‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study
The NetherlandsA study to evaluate the effects of obicetrapib and ezetimibe on cholesterol levels in adults with type 2 diabetes or metabolic syndrome
The NetherlandsA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
The NetherlandsA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
The NetherlandsLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on cardiovascular disease prevention and treatment, including trials evaluating new therapies for stroke, heart conditions, and vascular health.
Advanced research in lipoprotein management and antiplatelet therapies to reduce major cardiovascular events.
Innovative research in cancer treatment, particularly focusing on blood cancers and targeted therapies.
Trials investigating combination therapies and maintenance treatments for improved patient outcomes.
Clinical investigations into respiratory conditions and treatments, including studies on chronic conditions and inflammatory disorders.
Evaluation of novel therapeutic approaches for chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
